|
BBIO
|
BridgeBio Pharma, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
0.01%
|
US
|
NASDAQ
|
|
ATRI
|
ATRION Corporation
|
0.01%
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ATEC
|
Alphatec Holdings, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ATAI
|
ATAI Life Sciences N.V.
|
0.01%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.01%
|
US
|
NASDAQ
|
|
ANGO
|
AngioDynamics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
AMWL
|
American Well Corporation
|
0.01%
|
US
|
NYSE
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
AGTI
|
Agiliti, Inc.
|
0.01%
|
US
|
NYSE
|
|
AGEN
|
Agenus Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.01%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
0.01%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ACET
|
Adicet Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|